Phospho-Histone H2B (Ser32) Antibody

What is the significance of H2BS32 phosphorylation in chromatin biology?

H2BS32 phosphorylation represents a unique post-translational modification located within the histone core domain rather than in the histone tail. Unlike most well-characterized histone modifications that occur on histone tails, H2BS32 phosphorylation is positioned adjacent to the extreme N-terminus of the first helix of H2B (α1 helix) and between the grooves of the DNA double helix . This strategic location suggests that its phosphorylation could significantly influence nucleosome structure and DNA accessibility, potentially modulating chromatin compaction and gene expression patterns. The serine residue at position 32 is well-conserved among vertebrates but not in lower organisms, suggesting an evolutionarily acquired function in higher eukaryotes .

How does H2BS32 phosphorylation differ from other H2B phosphorylation sites?

H2BS32 phosphorylation differs significantly from other H2B phosphorylation sites in both location and function:

While H2BS14 phosphorylation serves as a hallmark of apoptosis and is increased during programmed cell death, H2BS32 phosphorylation is unrelated to apoptosis . This demonstrates that phosphorylation on the same histone molecule at different sites can result in very different biological functions.

How can I determine if H2BS32 phosphorylation is relevant to my research model?

To determine relevance to your research model, consider these approaches:

• Examine protein sequence conservation: Confirm that your model organism has the conserved Ser32 residue in H2B, which is primarily found in vertebrates .

• Assess baseline phosphorylation: In normal cycling cells, a baseline level of H2BS32 phosphorylation should be detectable. Compare this to serum-starved conditions where the phosphorylation is significantly reduced .

• Mitogen stimulation test: Treat your cells with mitogens like EGF and assess whether H2BS32 phosphorylation increases, as observed in the JB6 cell model .

• Cancer relevance: If studying cancer models, compare H2BS32 phosphorylation levels between your cancer cell lines/tissues and normal counterparts, as elevated levels have been observed in skin cancer cell lines .

How can I validate the specificity of a Phospho-Histone H2B (Ser32) antibody?

Rigorous validation of H2BS32ph antibody specificity is crucial for reliable research results. The following methodological approaches are recommended:

• Peptide competition assays: Pre-incubate the antibody with phosphorylated (H2BS32ph) and unmodified H2B peptides before immunoblotting or immunofluorescence. Specific binding should be blocked only by the phosphorylated peptide in a concentration-dependent manner .

• ELISA validation: Confirm that the antibody specifically binds to H2BS32ph peptide but not to the non-phosphorylated version of the peptide .

• Peptide dot blots: Demonstrate that the antibody does not cross-react with other sites of histone phosphorylation, such as H2BS14 .

• Western blot analysis with control samples: Test antibody reactivity against endogenous purified histones from cells with known H2BS32 phosphorylation status (e.g., serum-starved versus EGF-stimulated cells) .

• Immunofluorescence with blocking peptides: Perform immunofluorescence on stimulated cells with and without pre-incubation with specific (H2BS32ph) or non-specific (unmodified H2B) blocking peptides .

What are common pitfalls when using the Phospho-Histone H2B (Ser32) antibody in ChIP assays?

Several challenges may arise when using H2BS32ph antibodies in chromatin immunoprecipitation (ChIP) assays:

• Poor immunoprecipitation efficiency: H2BS32ph antibodies may immunoprecipitate nucleosomes very poorly, likely because H2BS32 is located close to the DNA gyres, making recognition of the epitope sterically hindered after cross-linking .

• Epitope masking: The positioning of Ser32 between the grooves of the DNA double helix can result in the phosphorylation site being partially obscured in the nucleosome structure, limiting antibody accessibility .

• Alternative approaches: If standard ChIP fails, consider:

  • Native ChIP (without formaldehyde cross-linking)

  • ChIP of epitope-tagged H2B (e.g., FLAG-H2B) followed by phosphorylation-specific detection

  • Sequential ChIP with a general H2B antibody followed by the phospho-specific antibody

• Verification approaches: Use cells expressing FLAG-tagged wild-type H2B versus H2BS32A mutant as controls to verify specificity of any ChIP signals .

What controls should be included in experiments using Phospho-Histone H2B (Ser32) antibody?

To ensure robust and reproducible results, include these essential controls:

• Peptide competition controls: Pre-incubate the antibody with phosphorylated and unphosphorylated peptides to confirm specificity .

• Phosphatase treatment: Treat some samples with lambda phosphatase to remove phosphorylation and confirm signal loss.

• Cell treatment controls:

  • Serum-starved cells (negative control with minimal H2BS32ph)

  • EGF-stimulated cells (positive control with increased H2BS32ph)

• H2BS32A mutant: Include cells expressing the non-phosphorylatable H2BS32A mutant as a negative control .

• RSK2 inhibition/knockdown: Include samples with RSK2 inhibition or knockdown to confirm the kinase-dependent nature of the signal .

What are the optimal conditions for detecting H2BS32 phosphorylation in cellular systems?

For optimal detection of H2BS32 phosphorylation, consider these methodological recommendations:

• Cell culture conditions:

  • For baseline detection: Use asynchronously growing cells

  • For stimulation experiments: Serum-starve cells (12-24 hours) followed by EGF treatment (50 ng/ml) for 15-30 minutes

• Histone extraction protocols:

  • For Western blot: Use acid extraction methods to enrich for histones

  • Separate soluble versus chromatin-bound fractions to determine incorporation of H2B into chromatin

• Immunofluorescence microscopy:

  • Fix cells with 4% paraformaldehyde

  • Include co-staining for phosphorylated RSK2 to confirm correlation

  • Use Hoechst staining to differentiate euchromatin/heterochromatin regions

• Western blot detection:

  • Use SDS-PAGE with 15-18% gels for optimal histone resolution

  • Transfer to PVDF membranes (preferred over nitrocellulose for small proteins)

  • Block with 5% BSA rather than milk (phospho-epitopes can be masked by casein phosphoproteins)

How can I study the functional impact of H2BS32 phosphorylation in cellular systems?

To investigate the functional consequences of H2BS32 phosphorylation, consider these experimental approaches:

• Mutant overexpression studies:

  • Generate stable cell lines expressing FLAG-tagged wild-type H2B versus H2BS32A mutant

  • Assess differences in:

    • Cell proliferation rates using MTS assay

    • Anchorage-independent growth using soft agar assays

    • AP-1 transcriptional activity using luciferase reporter assays

• Chromatin incorporation validation:

  • Perform mononucleosome immunoprecipitation to confirm incorporation of exogenous H2B into chromatin

  • Examine histones in soluble versus chromatin-bound fractions to confirm chromatin association

• Gene expression analysis:

  • Perform RT-qPCR or RNA-seq to identify differentially expressed genes

  • Focus on AP-1 target genes (c-jun, c-fos) in wild-type versus mutant cells

• Signaling pathway investigation:

  • Test the effects of H2BS32 phosphorylation on EGF-RSK2-AP-1 signaling axis

  • Examine potential crosstalk with other epigenetic modifications

What in vitro approaches can confirm RSK2 as the kinase for H2BS32?

To validate RSK2 as the kinase responsible for H2BS32 phosphorylation, employ these in vitro methodologies:

• In vitro kinase assays:

  • Use recombinant active RSK2 with purified H2B substrates

  • Include H2BS32A mutant as negative control

  • Detect phosphorylation by:

    • 32P incorporation for quantitative analysis

    • Western blot with H2BS32ph antibody for site-specific confirmation

• Substrate specificity analysis:

  • Test multiple histone substrates (H2A, H2B, H3, H4)

  • Compare phosphorylation of wild-type versus mutant H2B

  • Analyze phosphorylation in different substrate contexts:

    • Free histone H2B

    • Core histones (H3/H4/H2A/H2B)

    • Mononucleosomes

• Protein-protein interaction studies:

  • GST pulldown assays using GST-H2B and RSK2

  • Co-immunoprecipitation of FLAG-H2B and Xpress-RSK2

  • Reverse co-immunoprecipitation of Xpress-RSK2 and endogenous H2B

How does H2BS32 phosphorylation contribute to cancer development and cell transformation?

The relationship between H2BS32 phosphorylation and cancer development involves several key mechanisms:

• Elevated expression in cancer: H2BS32 phosphorylation is notably elevated in skin cancer cell lines and tissues compared with normal counterparts, suggesting a potential role as a cancer biomarker .

• Cell transformation: Using the JB6 Cl41 mouse skin epidermal cell model of tumor promoter-induced cell transformation, cells expressing non-phosphorylatable H2BS32A mutant exhibited:

  • Suppressed cell growth

  • Decreased EGF-induced cell transformation

  • Reduced colony formation in soft agar assays

  • Decreased activation of activator protein-1 (AP-1)

• Signaling pathway involvement: H2BS32 phosphorylation appears critical for controlling AP-1 activity, which is a major driver in cell transformation. This suggests that this modification may regulate genes involved in cellular proliferation and oncogenesis .

• Epigenetic mechanism: Located between the grooves of the DNA double helix, H2BS32 phosphorylation likely affects nucleosome structure and stability, potentially increasing DNA accessibility at specific gene loci related to cell transformation .

What is the relationship between RSK2, H2BS32 phosphorylation, and the EGF signaling pathway?

The RSK2-H2BS32-EGF relationship represents a complex signaling axis with multiple components:

• EGF stimulation pathway:

  • Serum-starved cells contain minimal H2BS32 phosphorylation

  • EGF treatment induces significant H2BS32 phosphorylation

  • This phosphorylation correlates with activation of RSK2

• RSK2 as the responsible kinase:

  • RSK2 directly phosphorylates H2BS32 in vitro

  • H2BS32 phosphorylation is attenuated in RSK2 knockout MEFs

  • H2BS32 phosphorylation is reduced in RSK2 knockdown JB6 cells

• Substrate recognition:

  • RSK2 recognizes the substrate motif R-X-X-(S/T) or R-X-(S/T)

  • H2BS32 is located within the RKRS32 sequence, matching this motif

• Colocalization and interaction:

  • Immunofluorescence shows that H2BS32ph colocalizes with phosphorylated RSK2

  • This colocalization occurs primarily in euchromatin regions, where active gene transcription takes place

  • The Manders' overlap coefficient of 0.8113 indicates a very strong correlation between H2BS32ph and phosphorylated RSK2

• Functional outcomes:

  • RSK2 is an important mediator of cell survival and tumor promoter-induced cell transformation

  • H2BS32 phosphorylation appears to mediate the effects of RSK2 on AP-1 activation and subsequent cellular responses

How might H2BS32 phosphorylation mechanistically affect chromatin structure and gene expression?

The mechanistic impact of H2BS32 phosphorylation on chromatin structure and gene expression likely involves several interrelated processes:

• Structural considerations:

  • H2BS32 is positioned adjacent to the extreme N terminus of the first H2B α-helix

  • It is located between the grooves of the DNA double helix

  • This position makes it an important determinant for the exit of the H2B N-terminal tail from the nucleosome

• Charge modification effects:

  • Phosphorylation introduces a negative charge close to the DNA

  • This likely affects the binding energies within the nucleosome

  • The altered electrostatic interactions could destabilize histone-DNA contacts

• Chromatin accessibility:

  • The modified nucleosomal/chromatin structure may favor DNA processing during gene activation

  • This could create a more permissive environment for transcription factor binding

  • The effect appears particularly important for genes involved in the AP-1 pathway

• Potential mechanisms:

  • Direct structural changes affecting nucleosome stability

  • Creation of binding sites for effector proteins ("phospho-readers")

  • Disruption of repressive chromatin interactions

  • Interplay with other histone modifications

How do I address inconsistent detection of H2BS32 phosphorylation across different experimental techniques?

When facing inconsistent results across different detection methods, consider these troubleshooting approaches:

• Antibody-related issues:

  • Batch-to-batch variability: Different antibody lots may have varying specificity and sensitivity

  • Fixation sensitivity: Some epitopes are destroyed by particular fixation methods

  • Application-specific optimization: An antibody that works for Western blotting may not work for immunofluorescence

• Technical considerations:

  • For Western blots: Ensure proper histone extraction and gel resolution

  • For immunofluorescence: Optimize fixation and permeabilization conditions

  • For ChIP assays: Consider the structural limitations described in the search results

• Biological variables:

  • Cell cycle stage: H2BS32 phosphorylation levels may vary throughout the cell cycle

  • Population heterogeneity: Consider single-cell approaches when population averages give inconsistent results

  • Signal transduction dynamics: The phosphorylation may be transient or oscillatory

• Validation approaches:

  • Use multiple antibodies targeting the same modification

  • Include positive and negative controls (H2BS32A mutant, phosphatase treatment)

  • Employ orthogonal detection methods (mass spectrometry-based approaches)

What are the limitations of using Phospho-Histone H2B (Ser32) antibody in clinical or diagnostic applications?

Several important limitations should be considered when using H2BS32ph antibodies in clinical contexts:

• Tissue preparation concerns:

  • Phosphorylation marks can be lost during tissue processing

  • Formalin fixation may mask the epitope

  • Phosphatases in tissue samples may dephosphorylate the site during handling

• Interpretation challenges:

  • Background staining in tissue sections can complicate analysis

  • Distinguishing specific nuclear signal from cytoplasmic background

  • Heterogeneity within tumor samples requiring careful evaluation

• Standardization issues:

  • Lack of standardized protocols across different laboratories

  • No established scoring systems for quantification

  • Limited commercial antibody options with validated clinical performance

• Research-to-clinical translation:

  • While H2BS32 phosphorylation is elevated in skin cancer cell lines, broader clinical validation across cancer types is needed

  • More research is needed to establish clear diagnostic or prognostic thresholds

  • The relationship to patient outcomes requires further investigation

How can I design experiments to study the interplay between H2BS32 phosphorylation and other histone modifications?

To investigate potential crosstalk between H2BS32 phosphorylation and other histone modifications, consider these experimental approaches:

• Sequential ChIP (Re-ChIP):

  • First immunoprecipitate with antibodies against known modifications

  • Then re-immunoprecipitate with H2BS32ph antibody (or vice versa)

  • This identifies regions with co-occurrence of both modifications

• Mass spectrometry analysis:

  • Perform proteomic analysis of histones isolated from cells under different conditions

  • Identify co-occurring modifications on the same H2B molecule

  • Quantify how modulation of H2BS32 phosphorylation affects other modifications

• Genetic approaches:

  • Generate cells expressing H2BS32A mutant

  • Analyze changes in global levels of other histone modifications

  • Perform ChIP-seq for various modifications to identify genome-wide patterns

• Enzyme inhibition studies:

  • Use RSK2 inhibitors to reduce H2BS32 phosphorylation

  • Examine effects on writers, erasers, and readers of other histone modifications

  • Test whether other modifications affect the ability of RSK2 to phosphorylate H2BS32

• Structural biology approaches:

  • Use molecular modeling to predict how H2BS32 phosphorylation might affect the deposition or recognition of nearby modifications

  • Consider the three-dimensional structure of the nucleosome and how different modifications might interact spatially